Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer
- 1 March 2001
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (5) , 583-590
- https://doi.org/10.1016/s0959-8049(00)00441-x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Vinorelbine: an overviewCancer Treatment Reviews, 1996
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancerLung Cancer, 1994
- Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?Journal of Clinical Oncology, 1993
- New aspects in the staging of lung cancer. Prospective validation of the international union against cancer TNM classificationCancer, 1992
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer GroupCancer Chemotherapy and Pharmacology, 1990
- Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized studyEuropean Journal of Cancer and Clinical Oncology, 1984